A commonly used blood pressure medication has been recalled over fears that it may be cross-contaminated with another drug. Glenmark Pharmaceuticals Inc. has recalled more than 11,100 bottles of ...
New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may ...
Among more than 4,000 patients with hormone receptor (HR)-positive disease, 3-year invasive disease-free survival (IDFS) ...
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...
The study thus suggests yet another unexpected avenue for the GLP-1 drugs.
New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may ...
An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass.
Giredestrant lowered the risk of disease recurrence or death by 30%, compared with standard-of-care endocrine therapy, according to the company.
Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients ...
Pfizer said on Tuesday it entered into an exclusive licensing agreement with YaoPharma, a subsidiary of China's Shanghai ...
A new study explains how cholesterol-lowering medications can lead to muscle damage and identifies a possible approach to making these treatments safer. Statins have dramatically improved cardiovascul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback